-
Je něco špatně v tomto záznamu ?
Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer
M Koleckova, J Ehrmann, J Bouchal, M Janikova, A Brisudova, J Srovnal, K Staffova, M Svoboda, O Slaby, L Radova, K Vomackova, B Melichar, L Veverkova, Z Kolar
Jazyk angličtina Země Velká Británie
Grantová podpora
NV16-31997A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Nature Open Access
od 2011-12-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
Springer Nature OA/Free Journals
od 2011-12-01
- MeSH
- apokrinní žlázy * mikrobiologie patologie MeSH
- dospělí MeSH
- epitelo-mezenchymální tranzice * genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikro RNA * genetika MeSH
- regulace genové exprese u nádorů genetika MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- signální dráha Wnt genetika MeSH
- stanovení celkové genové exprese MeSH
- triple-negativní karcinom prsu * genetika patologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
Triple negative breast cancers (TNBC) are a morphologically and genetically heterogeneous group of breast cancers with uncertain prediction of biological behavior and response to therapy. Epithelial to mesenchymal transition (EMT) is a dynamic process characterized by loss of typical epithelial phenotype and acquisition of mesenchymal characteristics. Aberrant activation of EMT can aggravate the prognosis of patients with cancer, however, the mechanisms of EMT and role of microRNAs (miRNAs) in EMT activation is still unclear. The aim of our study was to analyze miRNA expression within areas of TNBCs with cellular morphology that may be related to the EMT process and discuss possible associations. Out of all 3953 re-examined breast cancers, 460 breast cancers were diagnosed as TNBC (11.64%). With regard to complete tumor morphology preservation, the tissue samples obtained from core-cut biopsies and influenced by previous neoadjuvant therapy were excluded. We assembled a set of selected 25 cases to determine miRNA expression levels in relation to present focal spindle cell and apocrine cell morphology within individual TNBCs. We used descriptive (histological typing and morphology), morphometric, molecular (microdissection of tumor and non-tumor morphologies, RNA isolation and purification, microchip analysis) and bioinformatic analysis (including pathway analysis). The results were verified by quantitative real-time PCR (RT-qPCR) on an extended set of 70 TNBCs. The majority of TNBCs were represented by high-grade invasive carcinomas of no special type (NST) with medullary features characterized by well-circumscribed tumors with central necrosis or fibrosis and frequent tendency to spindle-cell and/or apocrine cell transformation. Apocrine and spindle cell transformation showed a specific miRNA expression profile in comparison to other tumor parts, in situ carcinoma or non-tumor structures, particularly down-regulated expression of hsa-miRNA-143-3p and hsa-miRNA-205-5p and up-regulated expression of hsa-miR-22-3p, hsa-miRNA-185-5p, and hsa-miR-4443. Apocrine cell tumor morphology further revealed decreased expression of hsa-miR-145-5p and increased expression of additional 14 miRNAs (e.g. hsa-miR-182-5p, hsa-miR-3135b and hsa-miR-4417). Pathway analysis for target genes of these miRNAs revealed several shared biological processes (i.e. Wnt signaling, ErbB signaling, MAPK signaling, endocytosis and axon guidance), which may in part contribute to the EMT and tumor progression. We provide the first miRNA expression profiling of specific tissue morphologies in TNBC. Our results demonstrate a specific miRNA expression profile of apocrine and spindle cell morphology which can exhibit a certain similarity with the EMT process and may also be relevant for prognosis and therapy resistance of TNBC.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22008184
- 003
- CZ-PrNML
- 005
- 20220404150508.0
- 007
- ta
- 008
- 220315s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-021-84350-2 $2 doi
- 035 __
- $a (PubMed)33664322
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Kolečková, Markéta, $d 1990- $7 xx0238146 $u Koleckova, Marketa. Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic.
- 245 10
- $a Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer / $c M Koleckova, J Ehrmann, J Bouchal, M Janikova, A Brisudova, J Srovnal, K Staffova, M Svoboda, O Slaby, L Radova, K Vomackova, B Melichar, L Veverkova, Z Kolar
- 520 9_
- $a Triple negative breast cancers (TNBC) are a morphologically and genetically heterogeneous group of breast cancers with uncertain prediction of biological behavior and response to therapy. Epithelial to mesenchymal transition (EMT) is a dynamic process characterized by loss of typical epithelial phenotype and acquisition of mesenchymal characteristics. Aberrant activation of EMT can aggravate the prognosis of patients with cancer, however, the mechanisms of EMT and role of microRNAs (miRNAs) in EMT activation is still unclear. The aim of our study was to analyze miRNA expression within areas of TNBCs with cellular morphology that may be related to the EMT process and discuss possible associations. Out of all 3953 re-examined breast cancers, 460 breast cancers were diagnosed as TNBC (11.64%). With regard to complete tumor morphology preservation, the tissue samples obtained from core-cut biopsies and influenced by previous neoadjuvant therapy were excluded. We assembled a set of selected 25 cases to determine miRNA expression levels in relation to present focal spindle cell and apocrine cell morphology within individual TNBCs. We used descriptive (histological typing and morphology), morphometric, molecular (microdissection of tumor and non-tumor morphologies, RNA isolation and purification, microchip analysis) and bioinformatic analysis (including pathway analysis). The results were verified by quantitative real-time PCR (RT-qPCR) on an extended set of 70 TNBCs. The majority of TNBCs were represented by high-grade invasive carcinomas of no special type (NST) with medullary features characterized by well-circumscribed tumors with central necrosis or fibrosis and frequent tendency to spindle-cell and/or apocrine cell transformation. Apocrine and spindle cell transformation showed a specific miRNA expression profile in comparison to other tumor parts, in situ carcinoma or non-tumor structures, particularly down-regulated expression of hsa-miRNA-143-3p and hsa-miRNA-205-5p and up-regulated expression of hsa-miR-22-3p, hsa-miRNA-185-5p, and hsa-miR-4443. Apocrine cell tumor morphology further revealed decreased expression of hsa-miR-145-5p and increased expression of additional 14 miRNAs (e.g. hsa-miR-182-5p, hsa-miR-3135b and hsa-miR-4417). Pathway analysis for target genes of these miRNAs revealed several shared biological processes (i.e. Wnt signaling, ErbB signaling, MAPK signaling, endocytosis and axon guidance), which may in part contribute to the EMT and tumor progression. We provide the first miRNA expression profiling of specific tissue morphologies in TNBC. Our results demonstrate a specific miRNA expression profile of apocrine and spindle cell morphology which can exhibit a certain similarity with the EMT process and may also be relevant for prognosis and therapy resistance of TNBC.
- 650 07
- $a dospělí $7 D000328 $2 czmesh
- 650 07
- $a senioři $7 D000368 $2 czmesh
- 650 07
- $a senioři nad 80 let $7 D000369 $2 czmesh
- 650 17
- $a apokrinní žlázy $x mikrobiologie $x patologie $7 D001050 $2 czmesh
- 650 17
- $a epitelo-mezenchymální tranzice $x genetika $7 D058750 $2 czmesh
- 650 07
- $a ženské pohlaví $7 D005260 $2 czmesh
- 650 07
- $a stanovení celkové genové exprese $7 D020869 $2 czmesh
- 650 07
- $a regulace genové exprese u nádorů $x genetika $7 D015972 $2 czmesh
- 650 07
- $a lidé $7 D006801 $2 czmesh
- 650 17
- $a mikro RNA $x genetika $7 D035683 $2 czmesh
- 650 07
- $a lidé středního věku $7 D008875 $2 czmesh
- 650 17
- $a triple-negativní karcinom prsu $x genetika $x patologie $7 D064726 $2 czmesh
- 650 07
- $a signální dráha Wnt $x genetika $7 D060449 $2 czmesh
- 700 1_
- $a Ehrmann, Jiří, $d 1967- $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic $7 jo2003163162
- 700 1_
- $a Bouchal, Jan, $d 1973- $7 xx0034399 $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
- 700 1_
- $a Janíková, Mária $7 xx0267892 $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
- 700 1_
- $a Brisudová, Aneta $7 xx026017701 $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
- 700 1_
- $a Srovnal, Josef $7 xx0091239 $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
- 700 1_
- $a Staffová, Kateřina $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
- 700 1_
- $a Svoboda, Marek, $d 1975- $7 xx0098478 $u Central European Institute of Technology, Masaryk University, 625 00, Brno, Czech Republic
- 700 1_
- $a Slabý, Ondřej, $d 1981- $7 js20030220015 $u Central European Institute of Technology, Masaryk University, 625 00, Brno, Czech Republic
- 700 1_
- $a Radová, Lenka $7 xx0092752 $u Central European Institute of Technology, Masaryk University, 625 00, Brno, Czech Republic
- 700 1_
- $a Vomáčková, Katherine $7 xx0142837 $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
- 700 1_
- $a Melichar, Bohuslav, $d 1965- $7 skuk0000853 $u Department of Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
- 700 1_
- $a Veverková, Lucie $7 xx0238149 $u Department of Radiology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
- 700 1_
- $a Kolář, Zdeněk, $d 1953- $7 jn20000710256 $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
- 773 0_
- $t Scientific Reports $g Roč. 11, č. 1 (2021), s. 5145 $p Sci. rep. $x 2045-2322 $w MED00182195
- 773 0_
- $p Sci. rep. $g 11(1):5145, 2021 03 04
- 910 __
- $a ABA008 $y p $z 0
- 990 __
- $a 20220315151054 $b ABA008
- 991 __
- $a 20220404150506 $b ABA008
- 999 __
- $a ok $b bmc $g 1770222 $s 1159378
- BAS __
- $a 3
- BMC __
- $a 2021 $b 11 $c 1 $d 5145 $x MED00182195 $i 2045-2322 $m Scientific reports
- GRA __
- $a NV16-31997A $p MZ0
- LZP __
- $a 2021-granty